Pascal E. Sanchez

4.5k citations

16 papers · 1.8k indexed · 1 hit paper · h-index 14

Impact in

Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
Cellular and Molecular Neuroscience top 5%
- Neuroscience and Neuropharmacology Research

Papers in ⓘ

Physiology 9
- Alzheimer's disease research and treatments 9
Hematology 3
- Erythropoietin and Anemia Treatment 3
- Iron Metabolism and Disorders 2

Co-authors: Lennart Mucke (8 shared papers)Kaitlyn Ho (7 shared papers)Nino Devidze (2 shared papers)Lei Zhu (2 shared papers)Laure Verret (3 shared papers)Keith Vossel (3 shared papers)Jorge J. Palop (3 shared papers)John R. Cirrito (1 shared paper)
Journals: Journal of Neuroscience (2 papers)Proceedings of the National Academy of Sciences (2 papers)Annals of Clinical and Translational Neurology (1 paper)Annals of Neurology (1 paper)Alzheimer s & Dementia (1 paper)
Partner nations: United States France China

In The Last Decade

Pascal E. Sanchez

16 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model 2012 · 489 citations

Peers

Countries citing papers authored by Pascal E. Sanchez

Since Specialization

Citations

This map shows the geographic impact of Pascal E. Sanchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal E. Sanchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal E. Sanchez more than expected).

Fields of papers citing papers by Pascal E. Sanchez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal E. Sanchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal E. Sanchez. The network helps show where Pascal E. Sanchez may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascal E. Sanchez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascal E. Sanchez Line = papers co-authored together Pascal E. Sanchez links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model Proceedings of the National Academy of Sciences ·Pascal E. Sanchez, Lei Zhu, Laure Verret, Keith Vossel, Anna G. Orr, John R. Cirrito, Nino Devidze, Kaitlyn Ho, Gui-Qiu Yu, Jorge J. Palop, Lennart Mucke Hit paper breakdown →	2012	489
2	Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-β Nature Neuroscience ·Elsa Suberbielle, Pascal E. Sanchez, Alexxai V. Kravitz, Xin Wang, Kaitlyn Ho, Kirsten Eilertson, Nino Devidze, Anatol C. Kreitzer, Lennart Mucke	2013	355
3	Life Extension Factor Klotho Prevents Mortality and Enhances Cognition in hAPP Transgenic Mice Journal of Neuroscience ·Dena B. Dubal, Lei Zhu, Pascal E. Sanchez, Kurtresha Worden, Lauren Broestl, Erik C. B. Johnson, Kaitlyn Ho, Gui-Qiu Yu, Daniel Kim, Alexander Betourne, Makoto Kuro‐o, Eliezer Masliah, Carmela R. Abraham, Lennart Mucke	2015	146
4	Standardized Environmental Enrichment Supports Enhanced Brain Plasticity in Healthy Rats and Prevents Cognitive Impairment in Epileptic Rats PLoS ONE ·Raafat Farès, Amor Belmeguenaï, Pascal E. Sanchez, Hayet Kouchi, Jacques Bodennec, Anne Morales, Béatrice Georges, Chantal Bonnet, Sandrine Bouvard, Robert S. Sloviter, Laurent Bezin	2013	112
5	Ablation of Cellular Prion Protein Does Not Ameliorate Abnormal Neural Network Activity or Cognitive Dysfunction in the J20 Line of Human Amyloid Precursor Protein Transgenic Mice Journal of Neuroscience ·Moustapha Cissé, Pascal E. Sanchez, Dong‐Hyun Kim, Kitty K. K. Ho, Gongqi Yu, Lennart Mucke	2011	106
6	Tau reduction prevents disease in a mouse model of Dravet syndrome Annals of Neurology ·Ania L. Gheyara, Ravikumar Ponnusamy, Biljana Djukic, Ryan Craft, Kaitlyn Ho, Weikun Guo, Mariel M. Finucane, Pascal E. Sanchez, Lennart Mucke	2014	99
7	Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus Neurobiology of Disease ·Jérémie Nadam, Fabrice Navarro, Pascal E. Sanchez, Colette Moulin, Béatrice Georges, Aël Laglaine, Jean-Marc Péquignot, Anne Morales, Philippe Ryvlin, Laurent Bezin	2006	86
8	Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons Proceedings of the National Academy of Sciences ·Pascal E. Sanchez, Raafat Farès, Jean‐Jacques Risso, Chantal Bonnet, Sandrine Bouvard, Marion Le-Cavorsin, Béatrice Georges, Colette Moulin, Amor Belmeguenaï, Jacques Bodennec, Anne Morales, Jean-Marc Péquignot, Etienne‐Emile Baulieu, Robert A. Levine, Laurent Bezin	2009	77
9	Leveraging preclinical models for the development of Alzheimer disease therapeutics Nature Reviews Drug Discovery ·Kimberly Scearce‐Levie, Pascal E. Sanchez, Joseph W. Lewcock	2020	76
10	Erythropoietin receptor expression is concordant with erythropoietin but not with common β chain expression in the rat brain throughout the life span The Journal of Comparative Neurology ·Pascal E. Sanchez, Fabrice Navarro, Raafat Farès, Jérémie Nadam, Béatrice Georges, Colette Moulin, Marion Le Cavorsin, Chantal Bonnet, Philippe Ryvlin, Amor Belmeguenaï, Jacques Bodennec, Anne Morales, Laurent Bezin	2009	51
11	Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer’s disease mutations but not by inhibition of BACE1 Molecular Neurodegeneration ·Erik C. B. Johnson, Kaitlyn Ho, Gui-Qiu Yu, Melanie Das, Pascal E. Sanchez, Biljana Djukic, Isabel Álvarez, Xinxing Yu, Michael Gill, Weiping Zhang, Jeanne T. Paz, Jorge J. Palop, Lennart Mucke	2020	45
12	Cross-species translation of the Morris maze for Alzheimer’s disease Journal of Clinical Investigation ·Katherine L. Possin, Pascal E. Sanchez, Clifford Anderson-Bergman, Roland Fernandez, Geoffrey A. Kerchner, Erica T. Johnson, Allyson Davis, Iris Lo, Nicholas T. Bott, Thomas Kiely, Michelle C. Fenesy, Bruce L. Miller, Joel H. Kramer, Steven Finkbeiner	2016	44
13	Network dysfunction inα‐synuclein transgenic mice and human Lewy body dementia Annals of Clinical and Translational Neurology ·Meaghan Morris, Pascal E. Sanchez, Laure Verret, Alexander J. Beagle, Weikun Guo, Dena B. Dubal, Kamalini G. Ranasinghe, Akihiko Koyama, Kaitlyn Ho, Gui‐Qiu Yu, Keith Vossel, Lennart Mucke	2015	44
14	Brain heparanase expression is up‐regulated during postnatal development and hypoxia‐induced neovascularization in adult rats Journal of Neurochemistry ·Fabrice Navarro, Raafat Farès, Pascal E. Sanchez, Jérémie Nadam, Béatrice Georges, Colette Moulin, Anne Morales, J. M. Pequignot, Laurent Bezin	2007	21
15	Les croyances collectives Que sais-je ? ·Pascal E. Sanchez	2009	2
16	P3‐463: Reducing epileptiform activity by levetiracetam rescues synaptic and cognitive functions in a mouse model of Alzheimer's disease Alzheimer s & Dementia ·Pascal E. Sanchez, Keith Vossel, Kaitlyn Ho, Daniel H. Kim, Gui‐Qiu Yu, Laure Verret, Jorge J. Palop, Lennart Mucke	2011	1

About Pascal E. Sanchez

Pascal E. Sanchez is a scholar working on Physiology, Hematology, Neurology, Developmental Neuroscience and Computational Theory and Mathematics, having authored 16 papers that have together received 1.8k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (9 papers), Computational Drug Discovery Methods (3 papers), Erythropoietin and Anemia Treatment (3 papers), Neuroscience and Neuropharmacology Research (3 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Iron Metabolism and Disorders (2 papers), Memory and Neural Mechanisms (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Neurology (274 citations), Cellular and Molecular Neuroscience (595 citations), Biological Psychiatry (77 citations), Physiology (740 citations) and Developmental Neuroscience (109 citations). Pascal E. Sanchez has collaborated with scholars based in United States, France and China. Frequent co-authors include Lennart Mucke, Kaitlyn Ho, Nino Devidze, Lei Zhu, Laure Verret, Keith Vossel, Jorge J. Palop, John R. Cirrito, Anna G. Orr and Kirsten Eilertson. Their work appears in journals such as Journal of Neuroscience, Proceedings of the National Academy of Sciences, Annals of Clinical and Translational Neurology, Annals of Neurology and Alzheimer s & Dementia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact